{"id":326,"date":"2023-09-04T06:42:04","date_gmt":"2023-09-04T06:42:04","guid":{"rendered":"https:\/\/drparhamacademy.com\/main\/?page_id=326"},"modified":"2025-03-31T23:30:55","modified_gmt":"2025-03-31T23:30:55","slug":"full-texts","status":"publish","type":"page","link":"https:\/\/drparhamacademy.com\/main\/full-texts\/","title":{"rendered":"Full-texts"},"content":{"rendered":"\n\n\n

Publication Library
<\/h1>\n\nFull access to our published articles<\/span><\/span><\/span>
\n\n\n\n\n\n\n
Publication list <\/u><\/h5>\n
(To directly download each PDF file, click on titles, please)<\/span><\/span><\/h5>
<\/h5><\/u><\/h5>\n\n\n\n\n\n\n
Guest editor in special issues:
<\/a><\/span><\/strong><\/h3>

<\/span><\/strong><\/a><\/p>
<\/span><\/strong><\/a><\/h5>\u201cRecent Advances of Receptor Tyrosine Kinases in Solid Tumors\u201d<\/span><\/strong><\/a><\/h5>
<\/span><\/strong><\/h5><\/span><\/span><\/span><\/span>
[<\/span><\/span>Biomedicines (Q1, JCR <\/span>IF= 4.7)<\/span>]<\/span><\/strong><\/span><\/strong><\/span><\/h6>\n<\/span>
<\/strong><\/h6>\u201cGlycobiology and Glycosylation: Deciphering the Secrets of Glycans in Humans and Pathogens\u201d<\/a><\/span><\/strong><\/h5><\/span><\/span>
<\/span><\/strong><\/h5><\/span>
<\/span><\/strong><\/p>
[<\/span><\/span>Frontiers in Immunology (Q1, JCR <\/span>IF= 7.3)<\/span>]<\/span><\/strong><\/span><\/strong><\/span>
<\/strong><\/h6>

<\/span><\/p>\n
Leading author in articles: <\/span><\/strong><\/h3>\nUnlocking c-MET: A comprehensive journey into targeted therapies for breast cancer<\/a><\/strong> (Cancer Letters, 2024) [Q1<\/strong>, Impact factor= 9.7]<\/li><\/ul>

<\/p>
Comprehensive assessment of TECENTRIQ^{\u00ae<\/sup> and OPDIVO^{\u00ae<\/sup>: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma<\/a> <\/strong>(Cancer and Metastasis Reviews, 2024) [Q1<\/strong><\/span>, Impact Factor= 10]<\/li><\/ul>
<\/p>}}Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions<\/a> <\/strong>(Biomedicines, 2024) [Q1<\/strong><\/span>, Impact Factor= 4.7]<\/li><\/ul>

<\/p>
Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates<\/strong><\/a> (American Journal of Cancer Research, 2022) [Q2<\/strong><\/span>, Impact Factor= 5.3]\u00a0 {More than 30 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\nPharmacotranscriptomic\n profiling of resistant triple-negative breast cancer cells treated with\n lapatinib and berberine shows upregulation of PI3K\/Akt signaling under \ncytotoxic stress<\/a><\/strong> (Gene, 2022)[Q2<\/strong><\/span>, Impact Factor= 3.5]<\/li><\/ul>

<\/p>
\n\n\n\nChemoresistance in breast cancer: PI3K\/Akt pathway inhibitors vs the current chemotherapy<\/a><\/strong> (American Journal of Cancer Research, 2021) [Q2<\/strong><\/span>, Impact Factor= 5.3] {More than 30 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n (<\/span><\/span><\/span><\/span><\/strong><\/a>HOT ARTICLE)<\/span><\/span><\/span><\/span><\/strong><\/a><\/span><\/a><\/span><\/a><\/span><\/a><\/span><\/a><\/strong> Akt-targeted\n therapy as a promising strategy to overcome drug resistance in breast \ncancer \u2013 A comprehensive review from chemotherapy to immunotherapy<\/a><\/strong> (Pharmacological Research, 2020) [TOP 10%<\/strong><\/span><\/span><\/span><\/strong><\/span><\/span><\/strong><\/span><\/strong>, Impact Factor= 9.3] {More than 120 times cited}<\/strong><\/li><\/ul>

<\/p>
\n\n\n\nTargets\n and mechanisms of sulforaphane derivatives obtained from cruciferous \nplants with special focus on breast cancer \u2013 contradictory effects and \nfuture perspectives<\/a><\/strong> (Biomedicine & Pharmacotherapy, 2020) [Q1<\/strong><\/span><\/a>, Impact Factor= 7.5] {More than 50 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\nMolecular\n Markers of Regulatory T Cells in Cancer Immunotherapy with Special \nFocus on Acute Myeloid Leukemia (AML) \u2013 A Systematic Review<\/a><\/strong> (Current Medicinal Chemistry, 2019) [Q<\/strong><\/span><\/a>2<\/strong><\/span>, Impact Factor= 4.1] {More than 20 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\nAntitumor\n effects of berberine against EGFR, ERK1\/2, P38 and AKT in MDA-MB231 and\n MCF-7 breast cancer cells using molecular modelling and in vitro study<\/a><\/strong> (Pharmacological Reports, 2019) [Q<\/strong><\/span><\/a>2<\/strong><\/span>, Impact Factor= 4.4] {More than 60 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\nMolecular\n modeling, dynamics simulations, and binding efficiency of berberine \nderivatives: A new group of RAF inhibitors for cancer treatment<\/a><\/strong> (PLOS ONE, 2018) [Q<\/strong><\/span><\/a>2<\/strong><\/span>, Impact Factor= 3.7] {More than 30 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\nMolecular\n Modelling of Berberine Derivatives as Inhibitors of Human Smoothened \nReceptor and Hedgehog Signalling Pathway Using a Newly Developed \nAlgorithm on Anti-Cancer Drugs<\/a><\/strong> (Recent Patents on Anti-Cancer Drug Discovery, 2017) [Q3<\/strong>, Impact Factor= 2.8] {More than 10 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n<\/strong>(HOT ARTICLE)<\/span><\/span><\/span><\/span><\/strong><\/a><\/span><\/a><\/span><\/a><\/span><\/a><\/span><\/a><\/strong><\/span><\/strong> MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment<\/strong> <\/a>(Pharmacological Research, 2015) [TOP 10%<\/strong><\/span><\/span><\/span>, Impact Factor= 9.3] {More than 150 times cited}<\/strong><\/span><\/strong><\/li><\/ul>

<\/p>
\n\n\n\n<\/strong><\/span><\/span><\/span><\/span><\/span>(HOT ARTICLE)<\/span><\/span><\/a><\/span><\/span><\/a><\/span><\/span><\/a><\/span> <\/span><\/a><\/strong>Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer<\/strong> <\/a>(European Journal of Pharmacology, 2014) [Q1<\/strong><\/span><\/a>, Impact Factor= 5] {More than 150 times cited}<\/strong><\/li><\/ul>
<\/p>\n
Co-author in articles: <\/strong><\/span><\/h3>\n<\/span><\/b><\/div>\n\n\n\n Comparative\n mRNA\/micro-RNA co-expression network drives melanomagenesis by \npromoting epithelial\u2013mesenchymal transition and vasculogenic mimicry \nsignaling<\/a> (Translational Oncology, 2021) [Q2<\/strong><\/span>, Impact Factor= 5]<\/li><\/ul>

<\/p>
\n\n\n\n Identification\n of cluster of differentiation molecule-associated microRNAs as \npotential therapeutic targets for gastrointestinal cancer immunotherapy<\/a> (International Journal of Biological Markers, 2021) [Q4<\/strong><\/span><\/strong>, Impact Factor= 2] {More than 10 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n (HOT ARTICLE) <\/span><\/span><\/span><\/span><\/strong><\/a>Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons<\/a> (Frontiers in Immunology, 2021) [Q1<\/strong><\/span>, Impact Factor= 7.3] {More than 100 times cited}<\/strong><\/li><\/ul>

<\/p>
\n\n\n\n PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer<\/a> (Scientific Reports, 2021) [Q2<\/strong><\/span>, Impact Factor= 4.6] {More than 10 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer<\/a> (Frontiers in Cellular and Infection Microbiology, 2021) [Q2<\/strong><\/span>, Impact Factor= 5.7] {More than 50 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma<\/a> (Frontiers in Immunology, 2021) [Q1<\/strong><\/span><\/strong>, Impact Factor= 7.3] {More than 60 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n Excessive Intake of Longan Arillus Alters gut Homeostasis and Aggravates Colitis in Mice<\/a> (Frontiers in Pharmacology, 2021) [Q1<\/strong><\/span>, Impact Factor= 5.6] {More than 20 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis<\/a> (International Journal of Biological Sciences, 2021) [Q1<\/strong><\/span>, Impact Factor= 9.2] {More than 30 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n m5C RNA Methylation Primarily Affects the ErbB and PI3K\u2013Akt Signaling Pathways in Gastrointestinal Cancer<\/a> (Frontiers in Molecular Biosciences, 2020) [Q2<\/strong><\/span>, Impact Factor= 5] {More than 20 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n Increased ABCC4 Expression Induced by ERRa Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer<\/a> (Frontiers in Oncology, 2020) [Q2<\/strong><\/span>, Impact Factor= 4.7] {More than 10 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n Analysis\n of Key Genes Regulating the Warburg Effect in Patients with \nGastrointestinal Cancers and Selective Inhibition of This Metabolic \nPathway in Liver Cancer Cells<\/a> (OncoTargets and Therapy, 2020) [Q2<\/strong><\/span>, Impact Factor= 4] {More than 20 times cited}<\/span><\/li><\/ul>
\n\n\n\n CD44\n inhibition attenuates EGFR signaling and enhances cisplatin sensitivity\n in human EGFR wild\u2011type non\u2011small\u2011cell lung cancer cells<\/a> (International Journal of Molecular Medicine, 2020) [Q2<\/strong><\/span>, Impact Factor= 5.4] {More than 40 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n Characterization of chemical composition and prebiotic effect of a dietary medicinal plant Penthorum chinense<\/em> Pursh<\/a> (Food Chemistry, 2020) [TOP 10%<\/strong><\/span><\/span><\/span>, Impact Factor= 8.8] {More than 50 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n Lapatinib as a Dual Tyrosine Kinase Inhibitor Unexpectedly Activates Akt in MDA-MB-231 Triple-Negative Breast Cancer Cells<\/a> (Letters in Drug Design & Discovery, 2020) [Q4<\/strong><\/span><\/strong>, Impact Factor= 1]<\/li><\/ul>

<\/p>
\n\n\n\n Natural\n killer cells as a double-edged sword in cancer immunotherapy: A \ncomprehensive review from cytokine therapy to adoptive cell \nimmunotherapy<\/a> (Pharmacological Research, 2020) [TOP 10%<\/strong><\/span><\/span><\/span>, Impact Factor= 9.3] {More than 30 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n Conditional reprogramming: next generation cell culture<\/a> (Acta Pharmaceutica Sinica B, 2020) [TOP 10%<\/strong><\/span><\/span><\/span>, Impact Factor= 14.5]{More than 50 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n A\n review of Penthorum chinense Pursh for hepatoprotection: Traditional \nuse, phytochemistry, pharmacology, toxicology and clinical trials<\/a> (Journal of Ethnopharmacology, 2020) [Q1<\/strong><\/span>, Impact Factor= 5.4] {More than 50 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n Comprehensive\n understanding of B7 family in gastric cancer: expression profile, \nassociation with clinicopathological parameters and downstream targets (International Journal of Biological Sciences, 2020) [Q1<\/strong><\/span>, Impact Factor= 9.2]<\/a> {More than 30 times cited}<\/span><\/li><\/ul>

<\/p>
\n\n\n\n Glyoxalase 1 gene improves the antistress capacity and reduces the immune inflammatory response<\/a> (BMC Genetics, 2019) [Q3<\/strong><\/span><\/strong>, Impact Factor= 2.9]<\/li><\/ul>
\n\n\n\n(HOT ARTICLE)<\/span><\/span><\/a><\/span><\/span><\/a><\/span><\/span><\/a><\/span><\/span><\/a><\/strong><\/strong><\/a> <\/span><\/a><\/strong><\/span><\/strong><\/span><\/strong>m1A Regulated Genes Modulate PI3K\/AKT\/mTOR and ErbB Pathways in Gastrointestinal Cancer<\/a> (Translational Oncology, 2019) [Q<\/strong><\/span><\/a>2<\/strong><\/span>, Impact Factor= 5] {More than 120 times cited}<\/strong><\/span><\/li><\/ul>\n\n\n\n\n
<\/p>
Research Impact<\/u><\/span><\/span><\/span><\/span>
<\/h1>\n
<\/p>
<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n<\/body>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"pagelayer_contact_templates":[],"_pagelayer_content":"","_uag_custom_page_level_css":"","footnotes":""},"class_list":["post-326","page","type-page","status-publish","hentry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"watson","author_link":"https:\/\/drparhamacademy.com\/main\/author\/watson\/"},"uagb_comment_info":0,"uagb_excerpt":null,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/drparhamacademy.com\/main\/wp-json\/wp\/v2\/pages\/326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drparhamacademy.com\/main\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/drparhamacademy.com\/main\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/drparhamacademy.com\/main\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drparhamacademy.com\/main\/wp-json\/wp\/v2\/comments?post=326"}],"version-history":[{"count":5,"href":"https:\/\/drparhamacademy.com\/main\/wp-json\/wp\/v2\/pages\/326\/revisions"}],"predecessor-version":[{"id":1158,"href":"https:\/\/drparhamacademy.com\/main\/wp-json\/wp\/v2\/pages\/326\/revisions\/1158"}],"wp:attachment":[{"href":"https:\/\/drparhamacademy.com\/main\/wp-json\/wp\/v2\/media?parent=326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}